Snippet from the press announcement:
A66, Inc., a Delaware Corporation, has introduced a compound named Haptenex. This compound is expected to revolutionize treatment for Alopecia Areata. The complex array of patented dermatological and systemically reactant compounds have the ability to cause the skin and other cells to react and distract the problem immune responses from damaging vulnerable follicular and other cells afflicted by immune system diseases.
Read the rest — A66, Inc. Introduces Alopecia Areata Immune Response Treatment
What I read in this news release does not impress me. The language is unclear and the press release doesn’t say anything in particular, so that is an alert for me. Be suspicious.